• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
Benchmark Analyst Maintains Buy Rating on Harvard Bioscience
12:42
Nov6
Harvard Bioscience released FY2025 9 Months earnings on November 6 Pre-Market EST, actual revenue USD 62.82 M, actual EPS USD -1.2231
14:30
Harvard Bioscience released FY2025 Q3 earnings on November 6 Pre-Market EST, actual revenue USD 20.59 M (forecast USD 20 M), actual EPS USD -0.03 (forecast USD -0.06)
14:30
Oct30
Harvard Bioscience to Release FY2025 Q3 Earnings on November 6, Pre-Market EST; Forecast Revenue USD 20M, EPS USD -0.06
00:11
Sep16
Harvard Bioscience Expands Distribution Agreement with Fisher Technologies, Includes US Market
11:03
Aug11
Harvard Bioscience released FY2025 Q2 earnings on August 11 During-Market EST, actual revenue USD 20.45 M (forecast USD 18.75 M), actual EPS USD -0.0515 (forecast USD -0.07)
20:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 20.59 M, Net Income -1.231 M, EPS -0.03

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 20.45 M, Net Income -2.282 M, EPS -0.0515

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 21.77 M, Net Income -50.34 M, EPS -1.1416

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More